BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1547791)

  • 1. Clinical experience in gynecological cancer management. d). Ovarian tumors--1) Epithelial: report from the Gynaecological Institutes of Padua University (1963-1990).
    Onnis A; Marchetti M; Maggino T; De Toffoli J; Blandamura S
    Eur J Gynaecol Oncol; 1992; 13(1):17-33. PubMed ID: 1547791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience in gynecological cancer management. Endometrial cancer: report from the gynecological institutes of Padua university (1963-1989).
    Onnis A; Marchetti M; Maggino T; Di Pasquale C; De Toffoli J
    Eur J Gynaecol Oncol; 1990; 11(1):1-11. PubMed ID: 2347329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience in gynaecological cancer management. D) Ovarian tumors--non-epithelial: report from the Gynaecological Institute of Padua University.
    Onnis A; Marchetti M; Piazza M
    Eur J Gynaecol Oncol; 1993; 14(1):5-17. PubMed ID: 8386083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience in gynecological cancer management. c). Cervical cancer: report from the Gynecologic Institutes of Padua University (1963-1989).
    Onnis A; Marchetti M; Maggino T; De Toffoli J; Piazza M
    Eur J Gynaecol Oncol; 1991; 12(1):11-26. PubMed ID: 2050155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer.
    Bian C; Yao K; Li L; Yi T; Zhao X
    Arch Gynecol Obstet; 2016 Jan; 293(1):163-168. PubMed ID: 26198168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advanced ovarian cancer: primary debulking (PDS) or neoadjuvant chemotherapy (NACT) - still a debate].
    Segev Y; Gemer O; Auslender R; Lavie O
    Harefuah; 2014 Sep; 153(9):527-31, 558. PubMed ID: 25417489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of Iranian patients with advanced ovarian cancer with neoadjuvant chemotherapy versus primary debulking surgery.
    Ghaemmaghami F; Karimi-Zarchi M; Modares-Gilani M; Mousavi A; Behtash N
    Asian Pac J Cancer Prev; 2008; 9(4):719-24. PubMed ID: 19256766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epithelial ovarian cancer].
    Hilpert F; Krause G; Venhoff L; Kühnle E; Schem C; Maass N
    Ther Umsch; 2007 Jul; 64(7):375-80. PubMed ID: 17948754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer.
    da Costa AA; Valadares CV; Baiocchi G; Mantoan H; Saito A; Sanches S; Guimarães AP; Achatz MI
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S971-8. PubMed ID: 26014155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.
    Muraji M; Sudo T; Iwasaki S; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Nishimura R
    Gynecol Oncol; 2013 Dec; 131(3):531-4. PubMed ID: 24096109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study.
    Spiliotis J; Halkia E; Lianos E; Kalantzi N; Grivas A; Efstathiou E; Giassas S
    Ann Surg Oncol; 2015 May; 22(5):1570-5. PubMed ID: 25391263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy.
    Signorelli M; Fruscio R; Ceppi L; Dell'anna T; Vitobello D; Chiappa V; Siesto G; Milani R; Landoni F; Mangioni C
    Gynecol Oncol; 2014 Feb; 132(2):312-5. PubMed ID: 24423881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer.
    Plotti F; Montera R; Aloisi A; Scaletta G; Capriglione S; Luvero D; De Cicco Nardone C; Basile S; Benedetti Panici P; Angioli R
    Eur J Surg Oncol; 2016 Mar; 42(3):383-90. PubMed ID: 26725211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy for ovarian cancer.
    Vergote I; van Gorp T; Amant F; Neven P; Berteloot P
    Oncology (Williston Park); 2005 Nov; 19(12):1615-22; discussion 1623-30. PubMed ID: 16396153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgery for advanced stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Ferron G; Narducci F; Pouget N; Touboul C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):197-213. PubMed ID: 30792175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma.
    Kuhn W; Rutke S; Späthe K; Schmalfeldt B; Florack G; von Hundelshausen B; Pachyn D; Ulm K; Graeff H
    Cancer; 2001 Nov; 92(10):2585-91. PubMed ID: 11745193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal debulking surgery is an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma.
    Wang PH; Yuan CC; Shyong WY; Chiang SC; Chao JY; Yen MS; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):220-5. PubMed ID: 10746418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced ovarian cancer patients with no evidence of disease after platinum-based chemotherapy: retrospective analysis of the role of second-look.
    Cacciari N; Zamagni C; Strocchi E; Pannuti F; Martoni A
    Eur J Gynaecol Oncol; 1999; 20(1):56-60. PubMed ID: 10422684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.